Confusion is abundant when it comes to understanding what the U.S. Food and Drug Administration expects from the drug industry in the way of label verification. "There is probably a lot of confusion" admits Paul Motise a top FDA compliance official. He should know. As the lead federal official for the long-running and confusing rulemaking on cut labels for pharmaceuticals he has probably unknowingly created the miasma. "This rule has been bounced around right and left. It's a mess. But we'll get it right." And it is not just the agency who is confused. Dan Gerner president of Packaging Coordinators Inc. (Philadelphia PA) which does contract packaging for pharmaceutical companies and others admits his customers are often unsure of FDA requirements. He is equally as foggy which is scary since his company has nine plants and 100 packaging lines around the country. He believed that the FDA requires automated label verification for the folding carton that holds a container. Wrong!